Target intelligence / Profile preview

Colon osmotic activity

Molecular classification
Other
01

Overview

Colon osmotic activity refers to the osmotic gradient that drives water movement across the colonic epithelium. This gradient is primarily established by active absorption of electrolytes—especially sodium through epithelial sodium channels (ENaC)—and the selective permeability of colonic epithelial cells. The process involves a coordinated system of channels and transporters, such as CFTR, ENaC, NKCC, and NHE, and is also influenced by solute concentration generated by organic acid metabolites from gut microbiota. Drugs such as osmotic laxatives work by increasing the osmolality of colonic contents to promote water retention in the stool and relieve constipation. Dysregulation of colon osmotic activity contributes to diseases such as diarrhea, constipation, IBS, ulcerative colitis, and cystic fibrosis. Note: "Colon osmotic activity" is not a well-defined pharmacological target such as a receptor or enzyme, and should not be listed as a canonical molecular entity. For drug targeting or biomarker purposes, specify the individual molecular components (like CFTR, ENaC, etc.) that regulate colonic osmotic gradients.

Other names
colon osmotic gradientcolonic water absorptioncolonic osmolalitycolonic fluid balance
02

Mechanism of action

Increase stool water content by raising colonic lumen osmolality, thereby drawing water in through osmosis. Retarding absorption of water by maintaining high solute concentrations (osmotic laxatives resist absorption, trapping water in stool).

03

Biological functions

Fluid and electrolyte absorptionWater reabsorption via osmotic gradientRegulation of stool consistency
04

Disease associations

Diarrhea (when osmotic activity is disturbed)Constipation (excessive water absorption)Irritable bowel syndromeUlcerative colitisCystic fibrosis (affecting ion transport and water movement)
05

Safety considerations

Electrolyte imbalance from excessive fluid loss or retentionRisk of dehydration or hypernatremia with improper drug usePossible worsening of colonic inflammation in susceptible patients
06

Interacting drugs

Osmotic laxatives (e.g., lactulose, polyethylene glycol)

1 more in the full profile.

Beyond the preview

Go deeper on Colon osmotic activity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colon osmotic activity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call